• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物在健康和疾病中的认知增强作用。

Cognitive enhancement by drugs in health and disease.

机构信息

UCL Institute of Cognitive Neuroscience and UCL Institute of Neurology, 17 Queen Square, London WC1N 3AR, UK.

出版信息

Trends Cogn Sci. 2011 Jan;15(1):28-36. doi: 10.1016/j.tics.2010.11.002. Epub 2010 Dec 9.

DOI:10.1016/j.tics.2010.11.002
PMID:21146447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3020278/
Abstract

Attempts to improve cognitive function in patients with brain disorders have become the focus of intensive research efforts. A recent emerging trend is the use of so-called cognitive enhancers by healthy individuals. Here, we consider some of the effects - positive and negative - that current drugs have in neurological conditions and healthy people. We conclude that, to date, experimental and clinical studies have demonstrated relatively modest overall effects, most probably because of substantial variability in response both across and within individuals. We discuss biological factors that might account for such variability and highlight the need to improve testing methods and to extend our understanding of how drugs modulate specific cognitive processes at the systems or network level.

摘要

改善脑疾病患者认知功能的尝试已成为密集研究工作的焦点。最近出现的一种新趋势是健康个体使用所谓的认知增强剂。在这里,我们考虑了一些当前药物在神经疾病和健康人群中的积极和消极影响。我们的结论是,到目前为止,实验和临床研究表明,总体效果相对较小,这很可能是因为个体之间和个体内部的反应存在很大差异。我们讨论了可能导致这种差异的生物学因素,并强调需要改进测试方法,并加深我们对药物如何在系统或网络水平上调节特定认知过程的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c5/3020278/dfdeaffb755b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c5/3020278/12b49331df46/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c5/3020278/8e111b9d714f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c5/3020278/dfdeaffb755b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c5/3020278/12b49331df46/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c5/3020278/8e111b9d714f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07c5/3020278/dfdeaffb755b/gr3.jpg

相似文献

1
Cognitive enhancement by drugs in health and disease.药物在健康和疾病中的认知增强作用。
Trends Cogn Sci. 2011 Jan;15(1):28-36. doi: 10.1016/j.tics.2010.11.002. Epub 2010 Dec 9.
2
Neuropharmacological strategies for understanding psychobiological determinants of cognition.理解认知的心理生物学决定因素的神经药理学策略。
Hum Neurobiol. 1987;6(2):119-27.
3
International Brain Research Organization--Seventh World Congress of Neuroscience. 12-17 July 2007, Melbourne, Victoria, Australia.国际脑研究组织——第七届世界神经科学大会。2007年7月12日至17日,澳大利亚维多利亚州墨尔本
IDrugs. 2007 Oct;10(10):690-2.
4
New Modalities in Drug Therapy: Modifying Ongoing Chemical Conversations in the Brain.药物治疗的新方法:改变大脑中正在进行的化学对话。
ACS Chem Neurosci. 2016 Nov 16;7(11):1472-1473. doi: 10.1021/acschemneuro.6b00330. Epub 2016 Oct 14.
5
The Potential of Carnosine in Brain-Related Disorders: A Comprehensive Review of Current Evidence.肌肽在与大脑相关的疾病中的潜力:当前证据的综合评价。
Nutrients. 2019 May 28;11(6):1196. doi: 10.3390/nu11061196.
6
60 years of advances in neuropsychopharmacology for improving brain health, renewed hope for progress.神经精神药理学 60 年的进步,改善大脑健康,为进展带来新希望。
Eur Neuropsychopharmacol. 2015 May;25(5):591-8. doi: 10.1016/j.euroneuro.2015.01.015. Epub 2015 Feb 7.
7
International Brain Research Organization--Sixth World Congress of Neuroscience. 10-15 July 2003, Prague, Czech Republic.国际脑研究组织——第六届世界神经科学大会。2003年7月10日至15日,捷克共和国布拉格。
IDrugs. 2003 Sep;6(9):852-4.
8
Treatment of attention deficits in neurological disorders.神经系统疾病中注意力缺陷的治疗。
Curr Opin Neurol. 2006 Dec;19(6):613-8. doi: 10.1097/01.wco.0000247605.57567.9a.
9
Closing thoughts for cognitive enhancement.关于认知增强的结语。
Handb Exp Pharmacol. 2015;228:451-9. doi: 10.1007/978-3-319-16522-6_16.
10
The ethics of elective psychopharmacology.择期精神药理学的伦理问题。
Int J Neuropsychopharmacol. 2012 May;15(4):559-71. doi: 10.1017/S146114571100037X. Epub 2011 Mar 14.

引用本文的文献

1
Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance.甲基苯丙胺引起的学习率动态适应性取决于基线表现。
Elife. 2025 Jul 21;13:RP101413. doi: 10.7554/eLife.101413.
2
Behavioral intervention with task repetition compared to pharmacological intervention with SSRI for enhancement of cognitive control in emotional and non-emotional settings.与使用选择性5-羟色胺再摄取抑制剂(SSRI)的药物干预相比,通过任务重复进行行为干预以增强在情绪和非情绪环境中的认知控制。
Psychopharmacology (Berl). 2025 Jun 19. doi: 10.1007/s00213-025-06835-6.
3
Development of a Printed Sensor and Wireless Measurement System for Urination Monitoring.

本文引用的文献

1
Individual differences in subconscious motor control predicted by GABA concentration in SMA.大脑中 SMA 区域 GABA 浓度可预测潜意识运动控制的个体差异。
Curr Biol. 2010 Oct 12;20(19):1779-85. doi: 10.1016/j.cub.2010.09.003. Epub 2010 Sep 30.
2
More GABA, less distraction: a neurochemical predictor of motor decision speed.更多 GABA,更少分心:运动决策速度的神经化学预测指标。
Nat Neurosci. 2010 Jul;13(7):825-7. doi: 10.1038/nn.2559. Epub 2010 May 30.
3
Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
用于排尿监测的印刷传感器及无线测量系统的开发。
Sensors (Basel). 2025 May 8;25(10):2961. doi: 10.3390/s25102961.
4
The Dark Side of "Smart Drugs": Cognitive Enhancement vs. Clinical Concerns.“聪明药”的阴暗面:认知增强与临床担忧
Toxics. 2025 Mar 26;13(4):247. doi: 10.3390/toxics13040247.
5
Neuroprotective effects of Indole 3-carbinol against Scopolamine-Induced cognitive and memory impairment in rats: modulation of oxidative stress, inflammatory and cholinergic pathways.吲哚 - 3 - 甲醇对东莨菪碱诱导的大鼠认知和记忆损伤的神经保护作用:对氧化应激、炎症和胆碱能通路的调节
Metab Brain Dis. 2025 Mar 18;40(4):154. doi: 10.1007/s11011-025-01577-y.
6
Evolving Landscape of Parkinson's Disease Research: Challenges and Perspectives.帕金森病研究的发展态势:挑战与展望
ACS Omega. 2025 Jan 8;10(2):1864-1892. doi: 10.1021/acsomega.4c09114. eCollection 2025 Jan 21.
7
The Cognitive Footprint of Medication Use.药物使用的认知足迹
Brain Behav. 2025 Jan;15(1):e70200. doi: 10.1002/brb3.70200.
8
Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance.甲基苯丙胺引起的学习率动态变化适应性取决于基线表现。
bioRxiv. 2025 Mar 20:2024.07.04.602054. doi: 10.1101/2024.07.04.602054.
9
Evaluating the Effects of Rivastigmine on Decision-Making in Patients with Mild Cognitive Impairment by Cambridge Neuropsychological Test Automated Battery (CANTAB); A Randomized, Double-Blind, Placebo-Controlled Trial.通过剑桥神经心理测试自动成套系统(CANTAB)评估卡巴拉汀对轻度认知障碍患者决策能力的影响:一项随机、双盲、安慰剂对照试验。
Iran J Pharm Res. 2023 Oct 30;22(1):e138943. doi: 10.5812/ijpr-138943. eCollection 2023 Jan-Dec.
10
Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution.新型多巴胺转运体抑制剂 CE-123 和莫达非尼的药代动力学:重点关注中枢神经系统分布。
Int J Mol Sci. 2023 Nov 29;24(23):16956. doi: 10.3390/ijms242316956.
帕金森病中的冲动控制障碍:一项对3090例患者的横断面研究。
Arch Neurol. 2010 May;67(5):589-95. doi: 10.1001/archneurol.2010.65.
4
Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review.莫达非尼和哌甲酯用于健康个体的神经增强:系统评价。
Pharmacol Res. 2010 Sep;62(3):187-206. doi: 10.1016/j.phrs.2010.04.002. Epub 2010 Apr 21.
5
Effects of modafinil and methylphenidate on visual attention capacity: a TVA-based study.莫达非尼和哌甲酯对视觉注意力容量的影响:基于 TVA 的研究。
Psychopharmacology (Berl). 2010 Jun;210(3):317-29. doi: 10.1007/s00213-010-1823-x. Epub 2010 Mar 30.
6
Neuroethical issues in cognitive enhancement.认知增强中的神经伦理学问题。
J Psychopharmacol. 2011 Feb;25(2):197-204. doi: 10.1177/0269881109106926. Epub 2010 Mar 8.
7
Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: a systematic review.乙酰胆碱酯酶抑制剂和盐酸美金刚用于健康个体的神经增强:系统评价。
Pharmacol Res. 2010 Jun;61(6):473-81. doi: 10.1016/j.phrs.2010.02.009. Epub 2010 Mar 1.
8
Escitalopram and enhancement of cognitive recovery following stroke.艾司西酞普兰与中风后认知功能恢复的增强
Arch Gen Psychiatry. 2010 Feb;67(2):187-96. doi: 10.1001/archgenpsychiatry.2009.185.
9
Positive effects of cholinergic stimulation favor young APOE epsilon4 carriers.胆碱能刺激对年轻的 APOE ε4 携带者有积极影响。
Neuropsychopharmacology. 2010 Apr;35(5):1090-6. doi: 10.1038/npp.2009.214. Epub 2010 Jan 13.
10
Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.在一个巴西成年 ADHD 患者样本中,DAT1 多态性对哌醋甲酯的反应没有影响。
J Neural Transm (Vienna). 2010 Feb;117(2):269-76. doi: 10.1007/s00702-009-0362-2. Epub 2010 Jan 5.